In breast cancer cells, PEAK1 mediates TGF-β receptor signals and integrin/Src/MAPK pathways and regulates TGF-β-induced epithelial–mesenchymal transition (EMT) and metastasis [15]. Here, PEAK1 is linked to breast cancer.